Regadenoson
NDC 0641-6253 · Hikma Pharmaceuticals USA Inc.
Generic nameRegadenoson
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)REGADENOSON ANHYDROUS
Strength.08 mg/mL
Pharmacologic classAdenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]
Marketing categoryANDA
Packages
0641-6253-01 — 1 SYRINGE, PLASTIC in 1 CARTON (0641-6253-01) / 5 mL in 1 SYRINGE, PLASTIC
Billed under HCPCS
J2785 — Injection, regadenoson, 0.1 mg Medicare Part B payment limit (ASP + 6%): $2.79
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0409-1401 — Regadenoson, 43598-616 — Regadenoson, 76329-3321 — Regadenoson